Panel Discussion: Navigating Rare Disease Drug Development Regulation Pathways

Time: 12:30 pm
day: Day Two


• With regulatory paths there is not a ‘one size fits all’ approach in rare disease, how can current pathways guide study planning across indications?
• What expertise is needed to plan for regulatory filing?
• How can CDx planning begin earlier when required for drug approval?